Increased risk of leukemia among sickle cell disease patients in California.
作者信息
Brunson Ann, Keegan Theresa H M, Bang Heejung, Mahajan Anjlee, Paulukonis Susan, Wun Ted
机构信息
Center for Oncology and Hematology Outcomes Research and Training (COHORT), Division of Hematology Oncology, School of Medicine.
Division of Biostatistics, Department of Public Health Sciences, School of Medicine, and.
出版信息
Blood. 2017 Sep 28;130(13):1597-1599. doi: 10.1182/blood-2017-05-783233. Epub 2017 Aug 22.
Abstract
摘要
相似文献
1
Increased risk of leukemia among sickle cell disease patients in California.加利福尼亚州镰状细胞病患者患白血病的风险增加。
Blood. 2017 Sep 28;130(13):1597-1599. doi: 10.1182/blood-2017-05-783233. Epub 2017 Aug 22.
2
Cancer specific survival in patients with sickle cell disease.镰状细胞病患者的癌症特异性生存。
Br J Haematol. 2019 Apr;185(1):128-132. doi: 10.1111/bjh.15687. Epub 2018 Nov 22.
3
Malignancy in patients with sickle cell disease.镰状细胞病患者的恶性肿瘤
Am J Hematol. 2003 Dec;74(4):249-53. doi: 10.1002/ajh.10427.
4
Using surveillance to determine the number of individuals with sickle cell disease in California and Georgia, 2005-2016.利用监测确定2005 - 2016年加利福尼亚州和佐治亚州镰状细胞病患者人数。
Pediatr Hematol Oncol. 2020 Nov;37(8):747-751. doi: 10.1080/08880018.2020.1779886. Epub 2020 Aug 12.
5
Association between hemolysis and albuminuria in adults with sickle cell anemia.成人镰状细胞贫血患者的溶血与蛋白尿之间的关联。
Haematologica. 2012 Feb;97(2):201-5. doi: 10.3324/haematol.2011.050336. Epub 2011 Oct 11.
6
Prevalence, Mortality, and Access to Care for Chronic Kidney Disease in Medicaid-Enrolled Adults With Sickle Cell Disease in California: Retrospective Cohort Study.加利福尼亚州参加医疗补助计划的镰状细胞病成年患者中慢性肾脏病的患病率、死亡率和获得治疗的情况：回顾性队列研究。
JMIR Public Health Surveill. 2024 Jul 15;10:e57290. doi: 10.2196/57290.
7
Blood disorders: sickle cell disease & leukemia--more similar than you may think.血液疾病：镰状细胞病和白血病——比你想象的更相似。
JEMS. 2003 Oct;28(10):72-84; quiz 86-7.
8
A method to identify California's sickle-cell disease population and its linkage to the California Cancer Registry.一种识别加利福尼亚州镰状细胞病患者群体及其与加利福尼亚癌症登记处关联的方法。
J Registry Manag. 2012 Summer;39(2):53-61.
9
Left ventricular dysfunction in sickle cell disease: the value of an electrocardiographic marker of increased risk of arrhythmia.镰状细胞病中的左心室功能障碍：心律失常风险增加的心电图标志物的价值。
Cardiovasc J Afr. 2011 Mar-Apr;22(2):59-60, 66.
10
Changes in lung function in children with sickle cell disease.镰状细胞病患儿的肺功能变化
Am J Respir Crit Care Med. 2009 Aug 15;180(4):377; author reply 377-8. doi: 10.1164/ajrccm.180.4.377.
引用本文的文献
1
Acute Promyelocytic Leukemia in a Patient With Sickle Cell Hemoglobin D Disease: A Case Report.镰状细胞血红蛋白D病患者的急性早幼粒细胞白血病：一例报告
Cureus. 2025 Jul 8;17(7):e87513. doi: 10.7759/cureus.87513. eCollection 2025 Jul.
2
To pursue gene therapy or not? Is it feasible after graft failure in allogeneic hematopoietic cell transplant recipients.是否进行基因治疗？对于异基因造血细胞移植受者移植失败后是否可行？
Blood Adv. 2025 Aug 12;9(15):3845-3852. doi: 10.1182/bloodadvances.2024015413.
3
Preclinical efficacy of a modified gamma-globin lentivirus gene therapy in Berkeley sickle cell anemia mice and human xenograft models.改良型γ-珠蛋白慢病毒基因疗法在伯克利镰状细胞贫血小鼠和人源异种移植模型中的临床前疗效
Mol Ther Methods Clin Dev. 2025 Feb 21;33(2):101439. doi: 10.1016/j.omtm.2025.101439. eCollection 2025 Jun 12.
4
Selecting patients with sickle cell disease for gene addition or gene editing-based therapeutic approaches: Report on behalf of a joint EHA Specialized Working Group and EBMT Hemoglobinopathies Working Party consensus conference.为基于基因添加或基因编辑的治疗方法选择镰状细胞病患者：代表欧洲血液学协会（EHA）专门工作组和欧洲血液与骨髓移植协会（EBMT）血红蛋白病工作组联合共识会议撰写的报告
Hemasphere. 2025 Mar 13;9(3):e70089. doi: 10.1002/hem3.70089. eCollection 2025 Mar.
5
Treating genetic blood disorders in the era of CRISPR-mediated genome editing.在CRISPR介导的基因组编辑时代治疗遗传性血液疾病。
Mol Ther. 2025 Jun 4;33(6):2645-2662. doi: 10.1016/j.ymthe.2025.01.031. Epub 2025 Jan 17.
6
The modern use of hydroxyurea for children with sickle cell anemia.羟基脲在镰状细胞贫血患儿中的现代应用。
Haematologica. 2025 May 1;110(5):1061-1073. doi: 10.3324/haematol.2023.284633. Epub 2025 Jan 9.
7
Adolescents and young adults with sickle cell disease exhibit accelerated aging with elevated T-cell p16 expression.患有镰状细胞病的青少年和青年表现出加速衰老，其T细胞p16表达升高。
Aging (Albany NY). 2024 Nov 14;16(21):13225-13236. doi: 10.18632/aging.206152.
8
Late effects of hemopoietic stem cell transplant for sickle cell disease: monitoring and management.镰状细胞病造血干细胞移植的晚期效应：监测与管理
Expert Rev Hematol. 2024 Dec;17(12):891-905. doi: 10.1080/17474086.2024.2423368. Epub 2024 Nov 5.
9
How I treat sickle cell disease with gene therapy.我如何用基因疗法治疗镰状细胞病。
Blood. 2024 Dec 26;144(26):2693-2705. doi: 10.1182/blood.2024024519.
10
UM171 enhances fitness and engraftment of gene-modified hematopoietic stem cells from patients with sickle cell disease.UM171 可提高镰状细胞病患者基因修饰造血干细胞的活力和植入效果。
Blood Adv. 2024 Nov 26;8(22):5885-5895. doi: 10.1182/bloodadvances.2024013932.
本文引用的文献
1
Osteonecrosis of the femoral head in sickle cell disease: prevalence, comorbidities, and surgical outcomes in California.镰状细胞病患者的股骨头坏死：加利福尼亚州的患病率、合并症及手术结果
Blood Adv. 2017 Jul 11;1(16):1287-1295. doi: 10.1182/bloodadvances.2017005256.
2
Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.镰状细胞病患者静脉血栓栓塞症发病率增加：危险因素、复发情况及对死亡率的影响。
Br J Haematol. 2017 Jul;178(2):319-326. doi: 10.1111/bjh.14655. Epub 2017 Apr 3.
3
Risk of individual malignant neoplasms in patients with sickle cell disease: English national record linkage study.镰状细胞病患者患个体恶性肿瘤的风险：英国全国记录链接研究
J R Soc Med. 2016 Aug;109(8):303-9. doi: 10.1177/0141076816651037. Epub 2016 Jun 20.
4
Defining Sickle Cell Disease Mortality Using a Population-Based Surveillance System, 2004 through 2008.利用基于人群的监测系统定义镰状细胞病死亡率，2004年至2008年
Public Health Rep. 2016 Mar-Apr;131(2):367-75. doi: 10.1177/003335491613100221.
5
Inflammation and cancer: advances and new agents.炎症与癌症：进展与新制剂
Nat Rev Clin Oncol. 2015 Oct;12(10):584-96. doi: 10.1038/nrclinonc.2015.105. Epub 2015 Jun 30.
6
Thalassaemia and risk of cancer: a population-based cohort study.地中海贫血与癌症风险：一项基于人群的队列研究。
J Epidemiol Community Health. 2015 Nov;69(11):1066-70. doi: 10.1136/jech-2014-205075. Epub 2015 Apr 28.
7
The accuracy of using ICD-9-CM codes to determine genotype and fever status of patients with sickle cell disease.使用国际疾病分类第九版临床修订本（ICD-9-CM）编码来确定镰状细胞病患者的基因型和发热状态的准确性。
Pediatr Blood Cancer. 2015 May;62(5):924-5. doi: 10.1002/pbc.25432. Epub 2015 Feb 12.
8
Age-related clonal hematopoiesis associated with adverse outcomes.与不良预后相关的年龄相关性克隆性造血。
N Engl J Med. 2014 Dec 25;371(26):2488-98. doi: 10.1056/NEJMoa1408617. Epub 2014 Nov 26.
9
Population based surveillance in sickle cell disease: methods, findings and implications from the California registry and surveillance system in hemoglobinopathies project (RuSH).镰状细胞病的基于人群的监测：来自加利福尼亚血红蛋白病登记与监测系统项目（RuSH）的方法、发现及启示
Pediatr Blood Cancer. 2014 Dec;61(12):2271-6. doi: 10.1002/pbc.25208. Epub 2014 Aug 30.
10
Sickle erythrocytes target cytotoxics to hypoxic tumor microvessels and potentiate a tumoricidal response.镰状红细胞将细胞毒素靶向低氧肿瘤微血管，并增强肿瘤杀伤反应。
PLoS One. 2013;8(1):e52543. doi: 10.1371/journal.pone.0052543. Epub 2013 Jan 9.
Zotero 插件